This section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Article content

VANCOUVER, British Columbia — Kardium Inc., a medical device solutions company behind the Globe® System, announced the launch of the “Globe Durability Guarantee”™, which is designed to provide patients and physicians with additional confidence in the Globe System’s ability to deliver durable treatment with only one procedure.

Sign In or Create an Account

or View more offersArticle content

The Globe Durability Guarantee promises that if a patient treated with the Globe System returns for a redo ablation and pulmonary vein reconnection is observed, then the hospital will be given a credit for a Globe device used in the redo procedure.1 “The Globe Durability Guarantee reflects our confidence in the exceptional durability profile observed in the clinical use of the Globe System,” said Kevin Chaplin, Chief Executive Officer of Kardium. “The Globe System is designed to deliver an effective and durable treatment for patients, the first time. And we want doctors to be confident that they are delivering an effective treatment in every procedure”

Article contentWe apologize, but this video has failed to load.Try refreshing your browser, or
tap here to see other videos from our team.Article content

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

The program is backed by data from multiple clinical studies of the Globe System which showed high durability of the treatment in patients, including the PULSAR IDE study, in which 95% of pulmonary veins remained durably isolated in patients undergoing repeat ablation, reflecting the efficacy and durability of the lesions created with the Globe System. The PULSAR IDE study also demonstrated 100% acute pulmonary vein isolation success, 78% freedom from atrial arrhythmia at 12 months, and 0% device-related primary safety events.2 The Globe System received FDA approval in August 2025.

Article contentArticle content

Atrial fibrillation (AF) affects more than 8 million people in the United States and nearly 50 million worldwide, and durable pulmonary vein isolation remains central to long-term procedural success and reduced repeat interventions.

Article content

The Globe System features a unique 122 electrode spherical array catheter that enables high-density mapping and is designed to support durable ablation all with a single device. By integrating mapping and ablation into a single catheter, the system is intended to improve procedure efficiency and enable electrophysiologists to treat atrial fibrillation more effectively.

Article content

More information on the Globe® System is available here: https://kardium.com/globe-system/About Kardium Inc. We are a rapidly growing, privately held medical solutions company with a mission to deliver the best treatment for atrial fibrillation through the Globe Pulsed Field System. Founded in 2007 and headquartered in Vancouver, Canada, Kardium has been recognized as a top company to work for in BC.

Article content1Article content

Terms and conditions apply; program details are available to eligible hospitals upon request.

Article content
Article content2Article content

Results may vary and may not predict outcomes in all clinical settings; see

Article contentPULSAR IDE studyArticle contentArticle contentArticle contentArticle contentView source version on businesswire.com: Article content

https://www.businesswire.com/news/home/20260910297161/en/

Article contentArticle content

Contacts

Article contentThis advertisement has not loaded yet.Trending


  1. Canada can afford to wait out Trump’s trade war, say two prominent policy vets

    Economy


  2. CRA denies tax credit to B.C. divorced dad paying child and spousal support

    Personal Finance

  3. Story continues belowThis advertisement has not loaded yet, but your article continues below.

  4. EU and Canada plan deal to boost trade, security as U.S. ties fray

    News


  5. Posthaste: Despite trade war, ‘Elbows up’ has its limits

    News


  6. PSP aims to boost Canadian investments by at least 30 per cent in coming years, CEO says

    News